Latest filings (excl ownership)
8-K
Kineta and TuHURA are collaborating on the ongoing Phase 1/Phase 2 clinical trial in patients with advance solid tumor cancer
2 Oct 24
8-K
Other Events
19 Sep 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Sep 24
8-K
Entry into a Material Definitive Agreement
13 Sep 24
8-K
Kineta Reopens Enrollment for the VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer
19 Aug 24
10-Q
2024 Q2
Quarterly report
8 Aug 24
8-K
Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences
8 Jul 24
8-K
Submission of Matters to a Vote of Security Holders
25 Jun 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 May 24
10-Q
2024 Q1
Quarterly report
15 May 24
8-K
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
15 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Entry into a Material Definitive Agreement
24 Apr 24
8-K
Departure of Directors or Certain Officers
18 Apr 24
8-K
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
8 Apr 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
21 Mar 24
8-K
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts
12 Mar 24
8-K
Kineta Announces Restructuring and Exploration of Strategic Alternatives
29 Feb 24
8-K
Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
17 Jan 24
8-K
Regulation FD Disclosure
5 Jan 24
8-K
Entry into a Material Definitive Agreement
15 Dec 23
EFFECT
Notice of effectiveness
15 Nov 23
424B3
Prospectus supplement
13 Nov 23
CORRESP
Correspondence with SEC
9 Nov 23
UPLOAD
Letter from SEC
9 Nov 23
8-K
Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
6 Nov 23
S-3
Shelf registration
3 Nov 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
3 Nov 23
8-K
Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
3 Nov 23
D
$2.89 mm in options / securities to be acquired, 1 investor
20 Oct 23
8-K
Entry into a Material Definitive Agreement
17 Oct 23
8-K
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5 Oct 23
424B5
Prospectus supplement for primary offering
5 Oct 23
8-K
Kineta Presents New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
4 Oct 23
8-K
Kineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial
3 Oct 23
8-K
Kineta to Participate in Upcoming Investor Conferences
31 Aug 23
Latest ownership filings
4
Richard Peters
5 Sep 24
4
Shawn Iadonato
5 Sep 24
4
Marion R Foote
5 Sep 24
4
Scott J. Dylla
5 Sep 24
4
Kimberlee C Drapkin
5 Sep 24
4
Raymond J. Bartoszek
5 Sep 24
4
David Arkowitz
5 Sep 24
SC 13D/A
Bartoszek Raymond J.
2 May 24
4
Raymond J. Bartoszek
2 May 24
4
Shawn Iadonato
16 Apr 24
4
CRAIG W. PHILIPS
16 Apr 24
4
Keith Baker
16 Apr 24
4
Thierry Guillaudeux
16 Apr 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13D/A
Iadonato Shawn
12 Feb 24
SC 13G/A
Magness Charles
12 Feb 24
4
Raymond J. Bartoszek
6 Dec 23
4
CRAIG W. PHILIPS
30 Nov 23
4
Shawn Iadonato
30 Nov 23
4
Marion R Foote
12 Oct 23
4
CRAIG W. PHILIPS
21 Sep 23
4
Pauline Kenny
21 Sep 23
4
Shawn Iadonato
21 Sep 23
4
Raymond J. Bartoszek
21 Sep 23
4
Keith Baker
19 Sep 23
4
Raymond J. Bartoszek
19 Sep 23
4
Thierry Guillaudeux
15 Sep 23
4
Scott J. Dylla
5 Jul 23
4
Kimberlee C Drapkin
5 Jul 23
3
Scott J. Dylla
5 Jul 23
3
Kimberlee C Drapkin
5 Jul 23
4
CRAIG W. PHILIPS
16 Jun 23
4
Pauline Kenny
16 Jun 23
4
Shawn Iadonato
16 Jun 23
4
Raymond J. Bartoszek
16 Jun 23
4
Keith Baker
16 Jun 23
4
CRAIG W. PHILIPS
14 Apr 23
4
Richard Peters
14 Apr 23
4
Pauline Kenny
14 Apr 23
4
Shawn Iadonato
14 Apr 23